Generalisation from phase III clinical trials: survival, quality of life, and health economics
- PMID: 9329528
- DOI: 10.1016/s0140-6736(97)03053-5
Generalisation from phase III clinical trials: survival, quality of life, and health economics
Comment in
-
From efficacy to cost-effectiveness.Lancet. 1997 Dec 13;350(9093):1781. doi: 10.1016/s0140-6736(05)63614-8. Lancet. 1997. PMID: 9413494 No abstract available.
-
From efficacy to cost-effectiveness.Lancet. 1997 Dec 13;350(9093):1781-2. doi: 10.1016/S0140-6736(05)63615-X. Lancet. 1997. PMID: 9413495 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources